TrialBMC medical research methodology2018

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).

Macey L Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.